S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.85%)
DIS   87.96 (+0.16%)
AMC   4.50 (-2.81%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.85%)
DIS   87.96 (+0.16%)
AMC   4.50 (-2.81%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.85%)
DIS   87.96 (+0.16%)
AMC   4.50 (-2.81%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.85%)
DIS   87.96 (+0.16%)
AMC   4.50 (-2.81%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:SWAV

Shockwave Medical (SWAV) Stock Forecast, Price & News

$275.09
-1.05 (-0.38%)
(As of 05:34 PM ET)
Compare
Today's Range
$271.77
$278.15
50-Day Range
$210.15
$302.68
52-Week Range
$154.45
$320.54
Volume
400,331 shs
Average Volume
548,601 shs
Market Capitalization
$10.07 billion
P/E Ratio
43.39
Dividend Yield
N/A
Price Target
$273.78

Shockwave Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
0.5% Downside
$273.78 Price Target
Short Interest
Healthy
3.58% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.51mentions of Shockwave Medical in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$7.12 M Sold Last Quarter
Proj. Earnings Growth
25.44%
From $3.97 to $4.98 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars

Medical Sector

217th out of 1,006 stocks

Surgical & Medical Instruments Industry

24th out of 104 stocks


SWAV stock logo

About Shockwave Medical (NASDAQ:SWAV) Stock

Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Stock News Headlines

Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market (SWAV)
Big pharma stocks Novartis, Eli Lilly, Merck, and Novo Nordisk are outperforming the market, driven by successful drugs and strong earnings growth.
Shockwave Medical, Fast Grower, In Boston Scientific's Sights?
Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave.
The 4th Military Revolution is Happening
. There have been 3 military revolutions in the past 100 years. The first was when the tank was invented in 1915. The second was the nuclear bomb in 1945. The third was the "smart bomb" in 1991. Amid the turmoil, there will be many losers. Click here to see how to win instead >>>
Are Small Caps a Harbinger of Market Declines? (SWAV)
The iShares Russell 2000 ETF outperformed the S&P 500 last week, but that may be short-lived. Small-cap momentum is often a bellwether for broad-market action.
Shockwave Medical (NASDAQ: SWAV)
Shockwave Medical Publishes 2022 ESG Report
The 4th Military Revolution is Happening
. There have been 3 military revolutions in the past 100 years. The first was when the tank was invented in 1915. The second was the nuclear bomb in 1945. The third was the "smart bomb" in 1991. Amid the turmoil, there will be many losers. Click here to see how to win instead >>>
Shockwave Medical Could Shock With an Upside Breakout
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Company Calendar

Last Earnings
5/08/2023
Today
5/31/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
1,001
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$273.78
High Stock Price Forecast
$325.00
Low Stock Price Forecast
$165.00
Forecasted Upside/Downside
-0.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

Net Income
$216 million
Pretax Margin
26.36%

Debt

Sales & Book Value

Annual Sales
$489.73 million
Cash Flow
$6.00 per share
Book Value
$15.59 per share

Miscellaneous

Free Float
35,356,000
Market Cap
$10.06 billion
Optionable
Not Optionable
Beta
0.99

Key Executives

  • Douglas Evan GodshallDouglas Evan Godshall
    President, Chief Executive Officer & Director
  • Mike Maszy
    Senior Vice President-Operations
  • Daniel Puckett
    Chief Financial Officer
  • Beaux Alexander
    Vice President-Clinical Affairs
  • W. Patrick Stephens
    Vice President-Research & Development













SWAV Stock - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is Shockwave Medical's stock price forecast for 2023?

9 brokers have issued 1 year price objectives for Shockwave Medical's shares. Their SWAV share price forecasts range from $165.00 to $325.00. On average, they predict the company's stock price to reach $273.78 in the next twelve months. This suggests that the stock has a possible downside of 1.5%.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2023?

Shockwave Medical's stock was trading at $205.61 at the beginning of the year. Since then, SWAV shares have increased by 35.2% and is now trading at $277.89.
View the best growth stocks for 2023 here
.

When is Shockwave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our SWAV earnings forecast
.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) issued its quarterly earnings data on Monday, May, 8th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.81 by $0.22. The company earned $161.10 million during the quarter, compared to analysts' expectations of $147.30 million. Shockwave Medical had a trailing twelve-month return on equity of 55.22% and a net margin of 43.18%. The business's revenue for the quarter was up 72.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.39 EPS.

What guidance has Shockwave Medical issued on next quarter's earnings?

Shockwave Medical updated its FY 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $700.00 million-$720.00 million, compared to the consensus revenue estimate of $671.58 million.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?

8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is Shockwave Medical's stock symbol?

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.38%), FMR LLC (7.16%), Price T Rowe Associates Inc. MD (3.82%), JPMorgan Chase & Co. (3.48%), State Street Corp (3.30%) and Artisan Partners Limited Partnership (2.90%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy, Sofinnova Capital Vii Fcpr and Trinh Phung.
View institutional ownership trends
.

How do I buy shares of Shockwave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Shockwave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $277.89.

How much money does Shockwave Medical make?

Shockwave Medical (NASDAQ:SWAV) has a market capitalization of $10.17 billion and generates $489.73 million in revenue each year. The company earns $216 million in net income (profit) each year or $6.34 on an earnings per share basis.

How many employees does Shockwave Medical have?

The company employs 1,001 workers across the globe.

How can I contact Shockwave Medical?

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -